These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

97 related items for PubMed ID: 7684827

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. [Comparison of the results of the treatment of patients with SSPE using various immunomodulating preparations].
    Sobczyk W, Kulczycki J, Piłkowska E, Iwińska B, Milewska D, Szmigielski S.
    Neurol Neurochir Pol; 1991; 25(5):626-33. PubMed ID: 1725554
    [Abstract] [Full Text] [Related]

  • 4. [Evaluation of the results of treatment of SSPE (subacute sclerosing panencephalitis) with isoprinosine].
    Filipowicz A, Grudzińska B.
    Neurol Neurochir Pol; 1987; 21(4-5):352-6. PubMed ID: 2451185
    [Abstract] [Full Text] [Related]

  • 5. [Propionibacterium granulosum KP-45 in the treatment of subacute sclerosing panencephalitis].
    Sobczyk W, Kulczycki J, Iwińska B, Vainiene M, Plachcińska J, Szmigielskí S, Pulverer G, Jeliaszewicź J.
    Psychiatr Neurol Med Psychol (Leipz); 1989 Jun; 41(6):344-51. PubMed ID: 2475877
    [Abstract] [Full Text] [Related]

  • 6. The effect of isoprinosine in subacute sclerosing panencephalitis (SSPE).
    Streletz LJ, Cracco J.
    Ann Neurol; 1977 Feb; 1(2):183-4. PubMed ID: 70187
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. [The evaluation of the use of antineoplaston AS2-1 treatment in subacute sclerosing panencephalitis].
    Sobczyk W, Piłkowska E, Iwińska-Buksowicz B.
    Neurol Neurochir Pol; 1999 Feb; 33(4):797-805. PubMed ID: 10612094
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. Isoprinosine therapy and SSPE.
    Huttenlocker PR.
    Ann Neurol; 1980 Dec; 8(6):642. PubMed ID: 6163393
    [No Abstract] [Full Text] [Related]

  • 15. Long-term study of isoprinosine in a case of subacute sclerosing panencephalitis.
    De Reuck JL, Boon PA, Krahel NL.
    Eur Neurol; 1985 Dec; 24(5):294-7. PubMed ID: 2414109
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Use of isoprinosine in subacute sclerosing panencephalitis.
    McGrath E, Rosenbloom L.
    Arch Dis Child; 1980 Oct; 55(10):829-30. PubMed ID: 6159826
    [No Abstract] [Full Text] [Related]

  • 19. Cerebrospinal fluid IgG changes in subacute sclerosing panencephalitis in the various stages of the disease and during isoprinosine therapy.
    Poloni M, Rocchelli B, Lanzi G, Rosano Burgio F, Besana D.
    Ital J Neurol Sci; 1981 May; 2(2):177-84. PubMed ID: 6174478
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 5.